WMS Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19,745
| Closed | -$1.96M | – | 177 |
|
|
2024
Q4 | $1.96M | Buy |
19,745
+289
| +1% | +$29.8K | 0.11% | 80 |
|
|
2024
Q3 | $2.21M | Buy |
19,456
+4,096
| +27% | +$487K | 0.12% | 72 |
|
|
2024
Q2 | $1.9M | Sell |
15,360
-207
| -1% | -$26.7K | 0.12% | 67 |
|
|
2024
Q1 | $2.05M | Sell |
15,567
-24
| -0.2% | -$2.96K | 0.14% | 63 |
|
|
2023
Q4 | $1.7M | Sell |
15,591
-795
| -5% | -$82.5K | 0.13% | 69 |
|
|
2023
Q3 | $1.69M | Sell |
16,386
-455
| -3% | -$49K | 0.13% | 67 |
|
|
2023
Q2 | $1.94M | Sell |
16,841
-36
| -0.2% | -$4.09K | 0.15% | 60 |
|
|
2023
Q1 | $1.8M | Sell |
16,877
-225
| -1% | -$24.3K | 0.16% | 67 |
|
|
2022
Q4 | $1.9M | Sell |
17,102
-796
| -4% | -$81.4K | 0.19% | 61 |
|
|
2022
Q3 | $1.54M | Buy |
17,898
+200
| +1% | +$17.9K | 0.21% | 60 |
|
|
2022
Q2 | $1.61M | Sell |
17,698
-23
| -0.1% | -$2.04K | 0.25% | 57 |
|
|
2022
Q1 | $1.45M | Sell |
17,721
-3,658
| -17% | -$288K | 0.2% | 63 |
|
|
2021
Q4 | $1.64M | Sell |
21,379
-3,060
| -13% | -$244K | 0.35% | 51 |
|
|
2021
Q3 | $1.84M | Buy |
24,439
+3,570
| +17% | +$272K | 0.27% | 52 |
|
|
2021
Q2 | $1.62M | Buy |
20,869
+2,548
| +14% | +$190K | 0.24% | 53 |
|
|
2021
Q1 | $1.35M | Buy |
18,321
+140
| +0.8% | +$10.3K | 0.31% | 53 |
|
|
2020
Q4 | $1.42M | Buy |
18,181
+809
| +5% | +$61.9K | 0.24% | 55 |
|
|
2020
Q3 | $1.38M | Buy |
17,372
+15
| +0.1% | +$1.18K | 0.27% | 55 |
|
|
2020
Q2 | $1.28M | Buy |
17,357
+14
| +0.1% | +$1.05K | 0.27% | 56 |
|
|
2020
Q1 | $1.27M | Buy |
17,343
+12
| +0.1% | +$943 | 0.35% | 47 |
|
|
2019
Q4 | $1.5M | Sell |
17,331
-678
| -4% | -$55.7K | 0.34% | 46 |
|
|
2019
Q3 | $1.45M | Sell |
18,009
-1,823
| -9% | -$146K | 0.35% | 45 |
|
|
2019
Q2 | $1.59M | Buy |
19,832
+6,222
| +46% | +$476K | 0.39% | 45 |
|
|
2019
Q1 | $1.08M | Buy |
13,610
+258
| +2% | +$19.3K | 0.27% | 53 |
|
|
2018
Q4 | $973K | Sell |
13,352
-1,488
| -10% | -$105K | 0.27% | 57 |
|
|
2018
Q3 | $1M | Sell |
14,840
-59
| -0.4% | -$3.76K | 0.11% | 79 |
|
|
2018
Q2 | $863K | Buy |
14,899
+1,194
| +9% | +$67.4K | 0.1% | 88 |
|
|
2018
Q1 | $712K | Buy |
13,705
+13
| +0.1% | +$702 | 0.08% | 93 |
|
|
2017
Q4 | $735K | Buy |
13,692
+1,094
| +9% | +$60.6K | 0.08% | 95 |
|
|
2017
Q3 | $770K | Buy |
12,598
+978
| +8% | +$59.3K | 0.09% | 95 |
|
|
2017
Q2 | $711K | Buy |
11,620
+590
| +5% | +$35.9K | 0.09% | 93 |
|
|
2017
Q1 | $669K | Buy |
11,030
+101
| +0.9% | +$6.13K | 0.08% | 98 |
|
|
2016
Q4 | $614K | Sell |
10,929
-428
| -4% | -$25K | 0.08% | 98 |
|
|
2016
Q3 | $676K | Buy |
11,357
+1,371
| +14% | +$80.2K | 0.09% | 90 |
|
|
2016
Q2 | $549K | Buy |
9,986
+665
| +7% | +$35.4K | 0.08% | 100 |
|
|
2016
Q1 | $471K | Sell |
9,321
-3
| -0% | -$147 | 0.07% | 120 |
|
|
2015
Q4 | $470K | Sell |
9,324
-318
| -3% | -$16K | 0.07% | 123 |
|
|
2015
Q3 | $454K | Sell |
9,642
-7,651
| -44% | -$406K | 0.07% | 121 |
|
|
2015
Q2 | $939K | Sell |
17,293
-1,423
| -8% | -$79.8K | 0.11% | 123 |
|
|
2015
Q1 | $1.03M | Buy |
18,716
+5,939
| +46% | +$336K | 0.13% | 118 |
|
|
2014
Q4 | $692K | Buy |
12,777
+1,446
| +13% | +$80.6K | 0.11% | 94 |
|
|
2014
Q3 | $641K | Buy |
11,331
+24
| +0.2% | +$1.35K | 0.1% | 121 |
|
|
2014
Q2 | $624K | Buy |
11,307
+1,671
| +17% | +$91.2K | 0.1% | 118 |
|
|
2014
Q1 | $522K | Buy |
9,636
+1,648
| +21% | +$85.3K | 0.08% | 132 |
|
|
2013
Q4 | $382K | Buy |
7,988
+57
| +0.7% | +$2.61K | 0.06% | 158 |
|
|
2013
Q3 | $361K | Buy |
7,931
+231
| +3% | +$10.5K | 0.07% | 133 |
|
|
2013
Q2 | $341K | Buy |
+7,700
| New | +$344K | 0.06% | 155 |
|
Other funds holding MRK
WMS Partners's MRK Position: Q1 2025 in Review
WMS Partners sold out of Merck (MRK) in Q1 2025, closing a stake of 19,745 shares — an estimated $1.96M sold.
WMS Partners first reported a position in MRK in Q2 2013 and held it in 47 quarters. The position peaked at $2.21M in Q3 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.
- WMS Partners reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
- WMS Partners sold 19,745 Merck shares in Q1 2025, an estimated $1.96M.
- WMS Partners first reported a position in Merck in Q2 2013 and held it in 47 quarters.
- WMS Partners's Merck position peaked at $2.21M in Q3 2024.
- 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.
Based on WMS Partners's 13F filing for Q1 2025.